DLTR
40
4
STZ
58
3
EMC
53
-3
DGX
48
-3
T
48
3
LB
63
-4
OXY
55
6
NRG
50
-2
SCHW
65
-2
PLD
56
8
BMY
61
-3
REGN
42
-2
HPE
70
2
NOC
40
-10
LOW
58
2
LEG
31
3
DOV
73
4
PNR
74
5
ETR
68
-3
TXT
62
2
DLTR
40
4
STZ
58
3
EMC
53
-3
DGX
48
-3
T
48
3
LB
63
-4
OXY
55
6
NRG
50
-2
SCHW
65
-2
PLD
56
8
BMY
61
-3
REGN
42
-2
HPE
70
2
NOC
40
-10
LOW
58
2
LEG
31
3
DOV
73
4
PNR
74
5
ETR
68
-3
TXT
62
2
Financhill
Back

LENZ Therapeutics Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Buy
89

LENZ
LENZ Therapeutics

Last Price:
35.79
Seasonality Move:
-7.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

LENZ Therapeutics Price Quote

$35.79
-0.60 (-1.65%)
(Updated: November 14, 2024 at 12:55 PM ET)

LENZ Therapeutics Key Stats

Buy
89
LENZ Therapeutics (LENZ) is a Buy
Day range:
$35.93 - $38.93
52-week range:
$14.07 - $37.51
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.76%
Volume:
195.4K
Avg. volume:
173K
1-year change:
126.02%
Market cap:
$1B
Revenue:
$15M
EPS:
$-5.24

How Much Does LENZ Therapeutics Make?

Data Unavailable

Is LENZ Therapeutics Growing As A Company?

Data Unavailable

LENZ Therapeutics Stock Price Performance

What Is LENZ Therapeutics 52-Week High & Low?

LENZ Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LENZ Therapeutics?

  • How Much Debt Does LENZ Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does LENZ Therapeutics Have?
    Cash and short term investments quarterly total is $217.1M
  • What Is LENZ Therapeutics’s Book Value Per Share?
    Book value per share is 7.83

Is LENZ Therapeutics Cash Flow Positive?

  • What Is LENZ Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.3M
  • What Is LENZ Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $197M
  • What Is LENZ Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$127.4M

LENZ Therapeutics Return On Invested Capital

Data Unavailable

LENZ Therapeutics Earnings Date & Stock Price

LENZ Therapeutics Competitors

  • Who Are LENZ Therapeutics's Competitors?
    Below is a list of companies who compete with LENZ Therapeutics or are related in some way:
    • Oruka Therapeutics Inc (ORKA)
    • PetMed Express Inc (PETS)
    • R1 RCM Inc (RCM)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LENZ Therapeutics Dividend Yield

LENZ Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.35%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 39.29
Upside from Last Price: 7.96%

Major Shareholders

  • How many LENZ shares are owned by institutional investors?
    29.7M LENZ shares are owned by institutional investors
  • How many LENZ shares are owned by insiders?
    242.8K LENZ shares are owned by insiders